Gynecologic Cancers
Debate: Surgery or Chemo First in Ovarian Cancer Treatment
BY CAROLINE SEYMOUR
FDA Approves Bevacizumab Biosimilar for 5 Cancer Types
BY BRIELLE BENYON
HIPEC in Ovarian Cancer: Is It for Everyone?
BY BRIELLE BENYON
Oral Contraceptives Decrease Risk of Ovarian Cancer Death
BY BRIELLE BENYON
Women with Ovarian Cancer Less Likely to Alert Providers As Symptoms Worsen
BY BETH FAND INCOLLINGO
Examining CIPN's Effects on Daily Lives
BY GRACE CAMPBELL, PHD, MSW, RN, CNL, CRRN
Language on Social Media Reveals Concerns of Patients with Ovarian Cancer
BY BETH FAND INCOLLINGO
Patient-Nurse Communication Is Key in Ovarian Cancer
BY BRIELLE BENYON
External Resources
MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747
Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747
Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.